
Sign up to save your podcasts
Or


Fallout from COVID-19 goes beyond case counts—we are facing “an epidemic of isolation and loneliness,” says Councilman Zeke Cohen. The Baltimore Neighbors Network is a virtual community of trained volunteers who are available to listen to city residents and provide resources for follow-up if needed.
Councilman Cohen, Shantay Jackson, executive director of the Baltimore Community Mediation Center, and Amy Greensfelder, executive director of Pro Bono Counseling, talk to Dr. Josh Sharfstein about how the network is addressing the mental health risks.
Published April 9, 2020
Development of a COVID-19 vaccine is an essential part of halting the pandemic. But will it be months or years before we see one? Vaccine expert Dr. William Moss talks to Stephanie Desmon about the complexities of vaccine development and manufacturing, potential hold ups, how opponents of vaccination may come into play, and why COVID-19 may threaten current immunization programs.
Published April 10, 2020
What will need to happen for businesses and schools to reopen, and what might the future look like with COVID-19? Former CDC director Tom Frieden talks to Stephanie Desmon about what governments and individuals should be doing right now to help curb the spread of the virus and move America closer to reopening.
Published April 9, 2020
There have been varying responses to COVID-19 carried out across local, state, and federal governments in the US. But what powers does the government have at various levels in a pandemic and how does the law work when an enemy like COVID-19 “does not respect jurisdictional boundaries?” Law expert and Hopkins professor Dr. Lainie Rutkow talks to Dr. Josh Sharfstein about a range of legal issues, including what happens if states start suing each other.
Published April 8, 2020
Why was the US slow to stand up testing and is this improving? Should you wear a cloth mask in your daily activities? Jason Farley, an infectious disease-trained nurse epidemiologist at the Johns Hopkins School of Nursing, talks to Stephanie Desmon and breaks down the complications of testing for COVID-19 and why recommendations on the public’s use of masks may be evolving.
Published April 8, 2020
Early on in the COVID-19 outbreak, Singapore quickly launched a robust response which included widespread testing, diligent contact tracing and quarantining, and isolation of all sick persons, even those with mild symptoms. Alumnus Dr. Vernon Lee, Director of Communicable Diseases at the Ministry of Health of Singapore, talks to Dr. Josh Sharfstein about how lessons from the 2003 SARS outbreak informed Singapore’s risk-based approach to staying a few steps ahead of the novel coronavirus.
Published April 7, 2020
Just two miles away from where the first case of COVID-19 was identified, the Hutchinson Institute for Cancer Outcomes Research acted quickly to help protect patients. Here to walk us through the impacts, barriers faced, and strategies that have been implemented to help address those challenges is the oncology center’s Senior Lead of Health Care Quality and Policy Dr. Gary Lyman.
Published April 10, 2020
Globally, more men are dying from COVID-19 than women. But is this due to sex (biological differences), gender (social and contextual differences), or something else entirely? Stephanie Desmon talks to virologist Sabra Klein and social scientist Rosemary Morgan about risk factors associated with COVID-19.
Published April 6, 2020
In 2014, Tolbert Nyenswah, then an assistant minister of health in Liberia, was tapped to lead the nation’s response to the Ebola epidemic. Under his leadership, an Incident Management System deployed thousands of epidemiologists, case managers, and contact tracers in a technical response that brought the outbreak under control. Nyenswah talks to Dr. Josh Sharfstein about what the US can learn from Liberia’s experience and what needs to happen soon to get ahead of the curve.
Published April 6, 2020
What does a global pandemic mean for the world’s drug supply chain? Howard Sklamberg, lawyer and former FDA deputy commissioner, talks to Dr. Josh Sharfstein about the threats that COVID-19 poses to medications for everything from cancer to diabetes to hypertension.
Published April 3, 2020